English | Español

Abbvie
Jamie Barrand | Jan 13, 2016

FDA grants priority review to new leukemia therapy
Jamie Barrand | Jan 8, 2016

FDA grants priority review to therapy for HCV, cirrhosis

Jamie Barrand | Jan 6, 2016

Study of follicular lymphoma combination therapy shows promise
Jamie Barrand | Dec 29, 2015

AbbVie researchers publish results of Venetoclax study
Jamie Barrand | Dec 3, 2015

FDA approves new drug application for hepatitis C therapy
Jamie Barrand | Dec 1, 2015

AbbVie launches hyperthyroidism education program
Jamie Barrand | Nov 20, 2015

AbbVie's hepatitis C drug study sees positive results
Jamie Barrand | Oct 10, 2015

AbbVie to market hepatitis C drug Viekirax in Japan

Trending
+ Community
Patient Daily | Mar 27, 2025

Healthcare professionals recognized at National Breathe Free conference for outstanding dedication
+ Regulatory
Patient Daily News Service | Mar 28, 2025

Former HHS Official: '340B program is just one of many reminders of the abuse and waste' in D.C.
+ Pharmaceuticals
Patient Daily | Mar 31, 2025

Founder of RXSaveCard on drug pricing: 'We typically see savings of $6,000+ per prescription'
+ Pharmaceuticals
Patient Daily | Apr 1, 2025

American Lung Association responds to HHS budget cuts